# Michael Breen
Episod podcast teratas
Dikemas kini:
michael breen (born 31 July 1952) is an English author, consultant and journalist covering North and South Korea.
Breen writes occasional opinion columns for international and South Korean media. Since 2000, he has written a featured column for The Korea Times, an English-language daily in South Korea, where he comments on South Korean society, culture, and political issues.
Episode 740: GT Biopharma ($GTBP) CEO on Expanding Into Solid Tumors and Key 2026 Catalysts
Solid tumors represent one of the largest and most challenging areas in cancer treatment. In this interview, GT Biopharma (NASDAQ: GTBP) CEO Michael Breen explains why the company is expanding its platform into solid tumors and how its NK engager technology is designed to activate the body’s nat ...
Episode 725: Advancing Humane Cancer Therapy: GT Biopharma's ($GTBP) Next-Gen Immunotherapy & Clinical Progress
A breakthrough that could reshape cancer treatment.GT Biopharma (NASDAQ: GTBP) is advancing its next generation TriKE® platform, an innovative immunotherapy that activates the body’s own natural killer cells to identify and destroy cancer. In this interview, Executive Chairman & CEO Michael Bree ...
Episode 703: GT Biopharma ($GTBP) Redefining Cancer Treatment Through Natural Killer Cell Immunotherapy
GT Biopharma (NASDAQ: GTBP) is pioneering a new era in cancer treatment: one that replaces cutting, burning, and poisoning with precision, safety, and the power of the body’s own immune system.In this interview, Executive Chairman & CEO Michael Breen and Consulting Senior Medical Director Dr. Je ...
Episode 689: GT Biopharma CEO on TriKE® Platform and Immunotherapy for Cancer & Autoimmune Diseases
What if cancer treatment could harness the body’s own immune system instead of relying on surgery, radiation, or chemotherapy? GT Biopharma (NASDAQ: GTBP) is developing its TriKE® platform, a novel NK cell engager designed to activate natural killer cells to seek out and destroy cancer.In this i ...
Episode 783: GT Biopharma ($GTBP) CEO on FDA Approval for New Investigational Drug Trial for Solid Tumor Cancer
This interview is disseminated on behalf of GT Biopharma. GT Biopharma (NASDAQ: GTBP) recently received approval from the U.S. Food and Drug Administration (FDA) for a new investigational drug trial for the solid tumor cancer treatment GTB-3650, as the race to develop a cure for cancer intensifi ...
Tipperary's Michael Breen interview - Across The Line March 27th, 2026
Listen back to the Friday March 27th 2026 edition of Across The Line as Paul Carroll looks ahead to the weekend's sporting action in Tipperary.
On this week's show:
- Tipperary defender Michael Breen chats about 2026 so far, recovering from injury and building towards the championship
- We he ...
Michael Breen: The Manchester Champion Behind the Breen Machine
Fresh from winning the PartyPoker Tour Manchester Main Event, Michael "Breen Machine" Breen joined me to reflect on the biggest victory of his poker career. Read the full article on Poker.pro.
Recorded immediately after his Manchester triumph, this conversation explores much more than the final ...
New rules on repairs and 'Economic Fury'!
New EU rules come into force today to encourage people to repair rather than replace broken appliances. Work and Technology correspondent, Brian O'Donovan joins host Karen Creed to explain how the new rules work and the types of devices that are covered under the new system.
Later, as the US th ...
ENJIN PENCARIAN PODCAST
Anda boleh menggunakan tapak web kami untuk mencari podcast3,825,430dan episod195,906,094mengikut orang, tempat atau topik.
Pelaburan dalam ilmu memberikan pulangan terbaik, jadi saya mendengar podcast.
‐ Benjamin "Llamacorn" Franklin
SUNTING
Terima kasih kerana membantu memastikan pangkalan data podcast dalam keadaan terkini.
